A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles

Analytical Biochemistry

Volumn 253, Issue 2, 1997, Pages 219-224

  Deitz, Anne C ^a   Doll, Mark A ^a,b   Hein, David W ^a,b  

^a Univ of N Dakota Sch of Medicine   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; GENES; POLYMERASE CHAIN REACTION;

EPIDEMIOLOGICAL STUDIES; GENETIC POLYMORPHISMS; HUMAN POPULATION; N-ACETYLTRANSFERASES; PCR-RFLP; RESTRICTION FRAGMENT LENGTH POLYMORPHISMS;

POLYMORPHISM;

ACYLTRANSFERASE;

ALLELE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0031573438     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1997.2379     Document Type: Article

References (25)

1. Weber W. W., Hein D. W. Pharmacol. Rev. 37:1985;25-79.
2. Kadlubar F. F., Butler M. A., Kaderlik K. R., Chou H. C., Lang N. P. Environ. Health Perspect. 98:1992;69-74.
3. Cartwright R. A., Glashan R. W., Rogers H. J., Ahmad R. A., Barham-Hall D., Higgins E., Kahn M. A. Lancet. 2:1982;842-846.
4. Risch A., Wallace D. M. A., Bathers S., Sim E. Hum. Mol. Genet. 4:1995;231-236.
5. Lang N. P., Chu D. Z. J., Hunter C. F., Kendall D. C., Flammang T. J., Kadlubar F. F. Arch. Surg. 121:1986;1259-1261.
6. Ilett K. F., David B. M., Detchon P., Castleden W. M., Kwa R. Cancer Res. 47:1987;1466-1469.
7. Wohlleb J. C., Hunter C. F., Blass B., Kadlubar F. F., Chu D. Z. J., Lang N. P. Int. J. Cancer. 46:1990;22-30.
8. Lang N. P., Butler M. A., Massengell J., Lawson M., Stotts R. C., Hauer-Jensen M., Kadlubar F. F. Cancer Epidemiol. Biomarkers Prev. 3:1994;675-682.
9. Roberts-Thomson I. C., Ryan P., Khoo K. K., Hart W. J., McMichael A. J., Butler R. N. Lancet. 347:1996;1372-1374.
10. Cascorbi I., Brockmoller J., Mrozikiewicz P. M., Bauer S., Loddenkemper R., Roots I. Cancer Res. 56:1996;3961-3966.
11. Ambrosone C. B., Freudenheim J. L., Graham S., Marshall J. R., Vena J. E., Brasure J. R., Michalek A. M., Laughlin R., Nemoto T., Gillenwater K. A., Harrington A. M., Shields P. G. J. Am. Med. Assoc. 276:1996;1494-1501.
12. Vatsis K. P., Weber W. W., Bell D. A., Dupret J.-M., Price Evans D. A., Grant D. M., Hein D. W., Lin H. J., Meyer U. A., Relling M. V., Sim E., Suzuki T., Yamazoe Y. Pharmacogenetics. 5:1995;1-17.
13. Vatsis K. P., Yao Y., Weber W. W. Am. J. Hum. Genet. 55:1994;A340.
14. Doll M. A., Jiang W., Deitz A. C., Rustan T. D., Hein D. W. Biochem. Biophys. Res. Commun. 233:1997;584-591.
15. Grant D. M., Hughes N. C., Janezic S. A., Goodfellow G. H., Chen H. J., Gaedigk A., Yu V. L., Grewal R. Mutat. Res. 376:1997;61-70.
16. Bell D. A., Stephens E. A., Castranio T., Umbach D. M., Watson M., Deakin M., Elder J., Hendrickse C., Duncan H., Strange R. C. Cancer Res. 55:1995;3537-3542.
17. Taylor J. A., Umbach D. M., Stephens E., Paulson D., Robertson C., Mohler J. C., Bell D. A. Proc. Am. Assoc. Cancer Res. 36:1995;282.
18. Olshan A., Watson M. A., Smith J., Wiessler M., Bell D. A. Proc. Am. Assoc. Cancer Res. 38:1997;331.
19. Katoh T., Bell D. A. Proc. Am. Assoc. Cancer Res. 38:1997;619.
20. Bell D. A., Badawi A. F., Lang N. P., Ilett K. F., Kadlubar F. F., Hirvonen A. Cancer Res. 55:1995;5226-5229.
21. Badawi A. F., Hirvonen A., Bell D. A., Lang N. P., Kadlubar F. F. Cancer Res. 55:1995;5230-5237.
22. Probst-Hensch N. M., Haile R. W., Li D. S., Sakamoto G. T., Louie A. D., Lin B. K., Frankl H. D., Lee E. R., Lin H. J. Carcinogenesis. 17:1996;2125-2129.
23. Doll M. A., Fretland A. J., Deitz A. C., Hein D. W. Anal. Biochem. 231:1995;413-420.
24. Vatsis K. P., Weber W. W. Arch. Biochem. Biophys. 301:1993;71-76.
25. Weber W. W., de Leon J. H., Vatsis K. P. Pharmacogenetics: Bridging the Gap Between Basic Science and Clinical Application. 1996;IBC Biomedical Library Series, Southborough. p. 1.3.1-1.3.13.